All In MedTech

Device Trial Radar · NCT05312164

Physio-Anatomy Clinical Data Collection Study

Last checked: Nov 20, 2026Latest source record: Mar 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Mar 14, 2022

Primary completion

Dec 31, 2025

Study completion Dec 31, 2025

Sponsor

Lead sponsor
Gentuity, LLCNot on our public-company list
Sponsor type
Industry
First posted
Apr 5, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

Conditions

  • Coronary Stenosis

Interventions

  • HF-OCT ImagingDevice

    Subjects undergo HF-OCT imaging of stenosed coronary arteries

  • FFR Pressure WireDevice

    Subjects undergo FFR physiology assessment of stenosed coronary arteries

  • AngiographyDevice

    Subjects undergo angiography imaging of stenosed coronary arteries

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Collection of angiography images, HF-OCT images, and FFR pressure wire dataTime frame: 2 years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Veteran's Administration Palo Alto

    Palo Alto, California · Recruiting

  • Tampa General Hospital

    Tampa, Florida · Recruiting

  • Atlanta VA Medical Center

    Decatur, Georgia · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.